HISA Anti-Doping and Medication Control

5 organizations filed 5 public comments on HISA Anti-Doping and Medication Control, at the Federal Trade Commission. The comment window closed 1265d ago.

Abstract

The Horseracing Integrity and Safety Act of 2020 recognizes a self-regulatory nonprofit organization, the Horseracing Integrity and Safety Authority, which is charged with developing proposed rules on a variety of subjects. Those proposed rules and later proposed rule modifications take effect only if approved by the Federal Trade Commission. The proposed rules and rule modifications must be published in the Federal Register for public comment. Thereafter, the Commission has 60 days from the date of publication to approve or disapprove the proposed rule or rule modification. The Authority submitted to the Commission a proposed rule on Anti-Doping and Medication Control on December 30,2022. The Office of the Secretary of the Commission determined that the proposal complied with the Commission’s rule governing such submissions. This document publicizes the Authority’s proposed rule’s text and explanation, and it seeks public comment on whether the Commission should approve or disapprove the proposed rule. This document is substantially similar to the document published on October 28, 2022, as corrected on November 4, 2022, and the Commission will consider all comments filed in response to that document as well as all comments filed in response to this document.

Commenters (5)

• Animal Welfare Institutetrade assoc.

  1 filing · confidence 97%
• Kentucky Horsemen's Benevolent and Protective Associationtrade assoc.

  1 filing · confidence 85%
• National Thoroughbred Racing Associationtrade assoc.

  1 filing · confidence 85%
• Thoroughbred Racing Association of Oklahomatrade assoc.

  1 filing · confidence 85%
• United States Trotting Associationtrade assoc.

  1 filing · confidence 85%